Invicta Diagnostic Limited
Bookbuilding IPO · NSE
- Price band
- ₹80 - ₹85
- Lot size
- 1,600 shares
- Issue amount
- ₹28.12 cr
- Total subscription
- 4.34×
- Opens
- 1 Dec 2025
- Closes
- 3 Dec 2025
- Allotment
- 4 Dec 2025
- Listing
- 8 Dec 2025
Offer at a glance
Issue overview
- Issue size
- 33,08,800 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,28,000
- Fresh issue
- ₹28.12 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,36,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 92,63,173
- Shares after issue
- 1,25,71,973
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 2 | 3,200 | ₹2,72,000 |
| sHNI | 3 | 4,800 | ₹4,08,000 |
| bHNI | 8 | 12,800 | ₹10,88,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 3 Dec 2025
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 3 |
| NIB | 0 | 407 |
| RETAIL | 396 | 1,363 |
| HNIs(10L +) | 75 | 189 |
| HNIs (2-10L) | 38 | 218 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 4.54 | 15.94 |
| Others | 0 | 15.94 |
| RETAIL | 10.77 | 37.07 |
| NIB | 4.61 | 33.5 |
| HNIs 2+ | 1.54 | 9.64 |
| HNIs 10+ | 3.07 | 23.85 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| EPS | 4.59 | 5.86 | 4.52 |
| ROE | 21.91 | 44.28 | 55.53 |
| ROCE | 22.8 | 42 | 56.04 |
| RONW | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 15.97 | 0 |
| POST IPO(PE) | 13.08 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Invicta Diagnostic Limited | 15.97 | 0 | 10.00 | 16.15 | 36.25 | 5.86 |
| Vijaya Diagnostic Centre Limited | 72.22 | 1007.4 | 1.00 | 77.86 | 17.99 | 13.95 |
| Krsnaa Diagnostics Limited | 34.39 | 826.8 | 5.00 | 272.54 | 8.79 | 24.04 |
Company information
Company profile
Incorporated in January 2021, Invicta Diagnostic Limited (operating as PC Diagnostics) is a Mumbai-based diagnostic services provider offering integrated radiology and pathology solutions through a hub-and-spoke model spread across the Mumbai Metropolitan Region, comprising a flagship advanced diagnostic hub in Thane West, three additional hubs in Bhayandar, Byculla, and Marol, and four spokes focused on basic imaging and sample collection; the company provides around 60 routine and 487 specialised pathology tests along with 96 basic and 130 advanced radiology tests, supported by a strong home-collection network and a team of 5 laboratory doctors, 20 radiologists, 127 technical staff, and 105 permanent employees as of May 31, 2025.
Strengths
- Expanding Footprint Across Mumbai Metropolitan Region: Rapid growth from one centre in 2021 to seven multi-format diagnostic facilities (hubs, spokes, and a central lab) enhances accessibility and strengthens market presence.
- Comprehensive & Affordable Diagnostic Services: A one-stop offering of pathology and radiology solutions delivers convenience, faster diagnostics, and cost-effective care for patients under the “PC Diagnostics” brand.
- Advanced Technology & Skilled Medical Team: Modern imaging infrastructure including CT, MRI, and PET CT systems supported by experienced radiologists ensures accurate, high-quality, and efficient diagnostic outcomes.
Risk factors
- High Sensitivity to Brand Image & Patient Experience: Heavy reliance on walk-in customers means even small lapses in service quality, test accuracy, or turnaround time can damage reputation and impact revenue growth.
- Operational Dependence on Flagship Thane Centre: Centralized processing of majority tests at one key facility exposes the business to major disruptions in case of equipment failure, regulatory issues, or unforeseen events.
- Geographic Concentration Risk in MMR: Entire revenue comes from the Mumbai Metropolitan Region, making performance highly vulnerable to regional economic, policy, or healthcare disruptions.
Promoters
Dr. Ketan Jayantilal Jain
Dr. Sanket Vinod Jain
Rohit Prakash Srivastava
Badal Kailash Naredi
Jayesh Prakash Jain
Registrar & documents
Lead manager
Socradamus Capital Private Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
1 GF, Plot 217, Ambavat Bhavan N.M Joshi Marg Delisle Road Mumbai, Maharashtra, 400013
022 - 4971 0036
[email protected]Company website ↗Frequently Asked Questions
What is Invicta Diagnostic IPO GMP today?
Currently, Invicta Diagnostic IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹85. Track daily updates on IPO Premiums as bidding numbers unfold.
What is the lot size and minimum investment for Invicta Diagnostic IPO?
The minimum bid lot size for Invicta Diagnostic IPO is 1,600 shares. At the cut-off price of ₹85 per share, retail investors need a minimum application amount of ₹1,36,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Invicta Diagnostic IPO allotment status be announced?
The allotment status for Invicta Diagnostic IPO is scheduled to be finalized on 4 Dec 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Invicta Diagnostic IPO allotment status online by PAN?
To check Invicta Diagnostic IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Invicta Diagnostic Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.